{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:12:56Z","timestamp":1791497576391,"version":"4.3.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,3,23]],"date-time":"2019-03-23T00:00:00Z","timestamp":1553299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Hagedorn Prize"},{"name":"Danish Diabetes Association"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00125-019-4848-7","type":"journal-article","created":{"date-parts":[[2019,3,23]],"date-time":"2019-03-23T16:03:31Z","timestamp":1553357011000},"page":"1024-1035","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":186,"title":["Metformin-induced changes of the gut microbiota in healthy young men: results of a non-blinded, one-armed intervention study"],"prefix":"10.1007","volume":"62","author":[{"given":"Thomas","family":"Bryrup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e6cilie W.","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Kern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine H.","family":"Allin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Brandslund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas R.","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Vestergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torben","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tue H.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluf","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2066-7895","authenticated-orcid":false,"given":"Trine","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,23]]},"reference":[{"issue":"8","key":"4848_CR1","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/JCI13505","volume":"108","author":"G Zhou","year":"2001","unstructured":"Zhou G, Myers R, Li Y et al (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108(8):1167\u20131174. \n                    https:\/\/doi.org\/10.1172\/JCI13505","journal-title":"J Clin Invest"},{"key":"4848_CR2","first-page":"241","volume":"7","author":"KA Coughlan","year":"2014","unstructured":"Coughlan KA, Valentine RJ, Ruderman NB, Saha AK (2014) AMPK activation: a therapeutic target for type 2 diabetes? Diabetes Metab Syndr Obes 7:241\u2013253","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"7436","key":"4848_CR3","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nature11808","volume":"494","author":"RA Miller","year":"2013","unstructured":"Miller RA, Chu Q, Xie J, Foretz M, Viollet B, Birnbaum MJ (2013) Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP. Nature 494(7436):256\u2013260. \n                    https:\/\/doi.org\/10.1038\/nature11808","journal-title":"Nature"},{"issue":"7","key":"4848_CR4","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1172\/JCI40671","volume":"120","author":"M Foretz","year":"2010","unstructured":"Foretz M, Hebrard S, Leclerc J et al (2010) Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1\/AMPK pathway via a decrease in hepatic energy state. J Clin Invest 120(7):2355\u20132369. \n                    https:\/\/doi.org\/10.1172\/JCI40671","journal-title":"J Clin Invest"},{"issue":"7506","key":"4848_CR5","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nature13270","volume":"510","author":"AK Madiraju","year":"2014","unstructured":"Madiraju AK, Erion DM, Rahimi Y et al (2014) Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature 510(7506):542\u2013546. \n                    https:\/\/doi.org\/10.1038\/nature13270","journal-title":"Nature"},{"issue":"1","key":"4848_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1185\/03007998409109558","volume":"9","author":"Enzo Bonora","year":"1984","unstructured":"Bonora E, Cigolini M, Bosello O et al (1984) Lack of effect of intravenous metformin on plasma concentrations of glucose, insulin, C-peptide, glucagon and growth hormone in non-diabetic subjects. Curr Med Res Opin 9(1):47\u201351. \n                    https:\/\/doi.org\/10.1185\/03007998409109558","journal-title":"Current Medical Research and Opinion"},{"issue":"2","key":"4848_CR7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.2337\/dc15-0488","volume":"39","author":"JB Buse","year":"2016","unstructured":"Buse JB, DeFronzo RA, Rosenstock J et al (2016) The primary glucose-lowering effect of metformin resides in the gut, not the circulation: results from short-term pharmacokinetic and 12-week dose-ranging studies. Diabetes Care 39(2):198\u2013205. \n                    https:\/\/doi.org\/10.2337\/dc15-0488","journal-title":"Diabetes Care"},{"issue":"7","key":"4848_CR8","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/S0006-2952(99)00396-2","volume":"59","author":"T Ikeda","year":"2000","unstructured":"Ikeda T, Iwata K, Murakami H (2000) Inhibitory effect of metformin on intestinal glucose absorption in the perfused rat intestine. Biochem Pharmacol 59(7):887\u2013890. \n                    https:\/\/doi.org\/10.1016\/S0006-2952(99)00396-2","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"4848_CR9","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nm.3787","volume":"21","author":"FA Duca","year":"2015","unstructured":"Duca FA, Cote CD, Rasmussen BA et al (2015) Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats. Nat Med 21(5):506\u2013511. \n                    https:\/\/doi.org\/10.1038\/nm.3787","journal-title":"Nat Med"},{"issue":"7418","key":"4848_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature11450","volume":"490","author":"J Qin","year":"2012","unstructured":"Qin J, Li Y, Cai Z et al (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490(7418):55\u201360. \n                    https:\/\/doi.org\/10.1038\/nature11450","journal-title":"Nature"},{"issue":"8","key":"4848_CR11","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.2337\/dc13-2817","volume":"37","author":"J Sato","year":"2014","unstructured":"Sato J, Kanazawa A, Ikeda F et al (2014) Gut dysbiosis and detection of \u201clive gut bacteria\u201d in blood of Japanese patients with type 2 diabetes. Diabetes Care 37(8):2343\u20132350. \n                    https:\/\/doi.org\/10.2337\/dc13-2817","journal-title":"Diabetes Care"},{"issue":"7452","key":"4848_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature12198","volume":"498","author":"FH Karlsson","year":"2013","unstructured":"Karlsson FH, Tremaroli V, Nookaew I et al (2013) Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498(7452):99\u2013103. \n                    https:\/\/doi.org\/10.1038\/nature12198","journal-title":"Nature"},{"issue":"2","key":"4848_CR13","doi-asserted-by":"publisher","first-page":"e9085","DOI":"10.1371\/journal.pone.0009085","volume":"5","author":"N Larsen","year":"2010","unstructured":"Larsen N, Vogensen FK, van den Berg FW et al (2010) Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 5(2):e9085. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0009085","journal-title":"PLoS One"},{"issue":"7581","key":"4848_CR14","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nature15766","volume":"528","author":"K Forslund","year":"2015","unstructured":"Forslund K, Hildebrand F, Nielsen T et al (2015) Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528(7581):262\u2013266. \n                    https:\/\/doi.org\/10.1038\/nature15766","journal-title":"Nature"},{"issue":"12","key":"4848_CR15","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1038\/s41591-018-0222-4","volume":"24","author":"L Sun","year":"2018","unstructured":"Sun L, Xie C, Wang G et al (2018) Gut microbiota and intestinal FXR mediate the clinical benefits of metformin. Nat Med 24(12):1919\u20131929. \n                    https:\/\/doi.org\/10.1038\/s41591-018-0222-4","journal-title":"Nat Med"},{"issue":"9","key":"4848_CR16","doi-asserted-by":"publisher","first-page":"e0204317","DOI":"10.1371\/journal.pone.0204317","volume":"13","author":"I Elbere","year":"2018","unstructured":"Elbere I, Kalnina I, Silamikelis I et al (2018) Association of metformin administration with gut microbiome dysbiosis in healthy volunteers. PLoS One 13(9):e0204317. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0204317","journal-title":"PLoS One"},{"key":"4848_CR17","doi-asserted-by":"crossref","unstructured":"de la Cuesta-Zuluaga J, Mueller NT, Corrales-Agudelo V et al (2017) Metformin is associated with higher relative abundance of mucin-degrading Akkermansia muciniphila and several short-chain fatty acid-producing microbiota in the gut. Diabetes Care 40:54\u201362","DOI":"10.2337\/dc16-1324"},{"issue":"7","key":"4848_CR18","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/nm.4345","volume":"23","author":"H Wu","year":"2017","unstructured":"Wu H, Esteve E, Tremaroli V et al (2017) Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat Med 23(7):850\u2013858. \n                    https:\/\/doi.org\/10.1038\/nm.4345","journal-title":"Nat Med"},{"issue":"2","key":"4848_CR19","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/dom.12811","volume":"19","author":"A Pingitore","year":"2017","unstructured":"Pingitore A, Chambers ES, Hill T et al (2017) The diet-derived short chain fatty acid propionate improves beta-cell function in humans and stimulates insulin secretion from human islets in vitro. Diabetes Obes Metab 19(2):257\u2013265. \n                    https:\/\/doi.org\/10.1111\/dom.12811","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"4848_CR20","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1084\/jem.20171965","volume":"215","author":"H Shapiro","year":"2018","unstructured":"Shapiro H, Kolodziejczyk AA, Halstuch D, Elinav E (2018) Bile acids in glucose metabolism in health and disease. J Exp Med 215(2):383\u2013396. \n                    https:\/\/doi.org\/10.1084\/jem.20171965","journal-title":"J Exp Med"},{"issue":"6285","key":"4848_CR21","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1126\/science.aad3369","volume":"352","author":"A Zhernakova","year":"2016","unstructured":"Zhernakova A, Kurilshikov A, Bonder MJ et al (2016) Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352(6285):565\u2013569. \n                    https:\/\/doi.org\/10.1126\/science.aad3369","journal-title":"Science"},{"issue":"6","key":"4848_CR22","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0002-9343(97)00254-4","volume":"103","author":"AJ Garber","year":"1997","unstructured":"Garber AJ, Duncan TG, Goodman AM, Mills DJ, Rohlf JL (1997) Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial. Am J Med 103(6):491\u2013497. \n                    https:\/\/doi.org\/10.1016\/S0002-9343(97)00254-4","journal-title":"Am J Med"},{"issue":"6","key":"4848_CR23","doi-asserted-by":"publisher","first-page":"755","DOI":"10.2337\/diacare.15.6.755","volume":"15","author":"CJ Bailey","year":"1992","unstructured":"Bailey CJ (1992) Biguanides and NIDDM. Diabetes Care 15(6):755\u2013772. \n                    https:\/\/doi.org\/10.2337\/diacare.15.6.755","journal-title":"Diabetes Care"},{"issue":"1","key":"4848_CR24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/clinchem\/36.1.15","volume":"36","author":"GR Warnick","year":"1990","unstructured":"Warnick GR, Knopp RH, Fitzpatrick V, Branson L (1990) Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints. Clin Chem 36(1):15\u201319","journal-title":"Clin Chem"},{"issue":"7","key":"4848_CR25","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412\u2013419. \n                    https:\/\/doi.org\/10.1007\/BF00280883","journal-title":"Diabetologia"},{"issue":"7","key":"4848_CR26","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJ, Holmes SP (2016) DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods 13(7):581\u2013583. \n                    https:\/\/doi.org\/10.1038\/nmeth.3869","journal-title":"Nat Methods"},{"issue":"16","key":"4848_CR27","doi-asserted-by":"publisher","first-page":"5261","DOI":"10.1128\/AEM.00062-07","volume":"73","author":"Q Wang","year":"2007","unstructured":"Wang Q, Garrity GM, Tiedje JM, Cole JR (2007) Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol 73(16):5261\u20135267. \n                    https:\/\/doi.org\/10.1128\/AEM.00062-07","journal-title":"Appl Environ Microbiol"},{"key":"4848_CR28","doi-asserted-by":"crossref","unstructured":"Hiippala K, Kainulainen V, Kalliomaki M, Arkkila P, Satokari R (2016) Mucosal prevalence and interactions with the epithelium indicate commensalism of Sutterella spp. Front Microbiol 7:1706","DOI":"10.3389\/fmicb.2016.01706"},{"issue":"10","key":"4848_CR29","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1136\/gutjnl-2014-307873","volume":"64","author":"A Lavelle","year":"2015","unstructured":"Lavelle A, Lennon G, O\u2019Sullivan O et al (2015) Spatial variation of the colonic microbiota in patients with ulcerative colitis and control volunteers. Gut 64(10):1553\u20131561. \n                    https:\/\/doi.org\/10.1136\/gutjnl-2014-307873","journal-title":"Gut"},{"key":"4848_CR30","doi-asserted-by":"publisher","first-page":"e00261","DOI":"10.1128\/mBio.00261-11","volume":"3","author":"BL Williams","year":"2012","unstructured":"Williams BL, Hornig M, Parekh T, Lipkin WI (2012) Application of novel PCR-based methods for detection, quantitation, and phylogenetic characterization of Sutterella species in intestinal biopsy samples from children with autism and gastrointestinal disturbances. MBio 3:e00261\u2013e00211","journal-title":"MBio"},{"issue":"1","key":"4848_CR31","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1186\/s12864-017-4195-3","volume":"18","author":"X Guo","year":"2017","unstructured":"Guo X, Li S, Zhang J et al (2017) Genome sequencing of 39 Akkermansia muciniphila isolates reveals its population structure, genomic and functional diverisity, and global distribution in mammalian gut microbiotas. BMC Genomics 18(1):800. \n                    https:\/\/doi.org\/10.1186\/s12864-017-4195-3","journal-title":"BMC Genomics"},{"issue":"5","key":"4848_CR32","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1136\/gutjnl-2012-303839","volume":"63","author":"NR Shin","year":"2014","unstructured":"Shin NR, Lee JC, Lee HY et al (2014) An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 63(5):727\u2013735. \n                    https:\/\/doi.org\/10.1136\/gutjnl-2012-303839","journal-title":"Gut"},{"issue":"11","key":"4848_CR33","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1017\/S0007114516004086","volume":"116","author":"Camilla Pedersen","year":"2016","unstructured":"Pedersen C, Gallagher E, Horton F et al (2016) Host-microbiome interactions in human type 2 diabetes following prebiotic fibre (galacto-oligosaccharide) intake. Br J Nutr 116:1869\u20131877","journal-title":"British Journal of Nutrition"},{"issue":"3","key":"4848_CR34","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1136\/gutjnl-2014-308778","volume":"65","author":"MC Dao","year":"2016","unstructured":"Dao MC, Everard A, Aron-Wisnewsky J et al (2016) Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut 65(3):426\u2013436. \n                    https:\/\/doi.org\/10.1136\/gutjnl-2014-308778","journal-title":"Gut"},{"issue":"4","key":"4848_CR35","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1078\/07232020260517625","volume":"25","author":"MR Garner","year":"2002","unstructured":"Garner MR, Flint JF, Russell JB (2002) Allisonella histaminiformans gen. nov., sp. nov. A novel bacterium that produces histamine, utilizes histidine as its sole energy source, and could play a role in bovine and equine laminitis. Syst Appl Microbiol 25(4):498\u2013506. \n                    https:\/\/doi.org\/10.1078\/07232020260517625","journal-title":"Syst Appl Microbiol"},{"issue":"5","key":"4848_CR36","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/ajcn\/85.5.1185","volume":"85","author":"L Maintz","year":"2007","unstructured":"Maintz L, Novak N (2007) Histamine and histamine intolerance. Am J Clin Nutr 85(5):1185\u20131196. \n                    https:\/\/doi.org\/10.1093\/ajcn\/85.5.1185","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"4848_CR37","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s10928-015-9436-y","volume":"42","author":"SW Yee","year":"2015","unstructured":"Yee SW, Lin L, Merski M et al (2015) Prediction and validation of enzyme and transporter off-targets for metformin. J Pharmacokinet Pharmacodyn 42(5):463\u2013475. \n                    https:\/\/doi.org\/10.1007\/s10928-015-9436-y","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"6285","key":"4848_CR38","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1126\/science.aad3503","volume":"352","author":"G Falony","year":"2016","unstructured":"Falony G, Joossens M, Vieira-Silva S et al (2016) Population-level analysis of gut microbiome variation. Science 352(6285):560\u2013564. \n                    https:\/\/doi.org\/10.1126\/science.aad3503","journal-title":"Science"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-019-4848-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-019-4848-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-019-4848-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,22]],"date-time":"2020-03-22T00:23:54Z","timestamp":1584836634000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-019-4848-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,23]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["4848"],"URL":"https:\/\/doi.org\/10.1007\/s00125-019-4848-7","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,23]]},"assertion":[{"value":"20 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there is no duality of interest associated with this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Duality of interest"}}]}}